NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes
Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.
Zacks Investment Research8/6/2026Positive
NGVT
Ingevity CorpNYSEBASIC MATERIALSSPECIALTY CHEMICALS
Key Statistics
Market Cap
$2.64B
P/E Ratio
108.13
EPS
$0.71
Beta
1.18
52W High
$79.29
52W Low
$45.85
50-Day MA
$73.31
200-Day MA
$67.19
Dividend Yield
—
Profit Margin
4.65%
Forward P/E
9.97
PEG Ratio
2.41
About Ingevity Corp
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company is headquartered in North Charleston, South Carolina.
Fundamentals
| Revenue (TTM) | $1.16B |
| Gross Profit (TTM) | $477.20M |
| EBITDA | $372.60M |
| Operating Margin | 29.90% |
| Return on Equity | 30.10% |
| Return on Assets | 10.40% |
| Revenue/Share (TTM) | $32.69 |
| Book Value | $1.36 |
| Price-to-Book | 56.27 |
| Price-to-Sales (TTM) | 2.27 |
| EV/Revenue | 3.256 |
| EV/EBITDA | 18.25 |
| Quarterly Earnings Growth (YoY) | 199.00% |
| Quarterly Revenue Growth (YoY) | -5.20% |
| Shares Outstanding | $34.38M |
| Float | $34.04M |
| % Insiders | 0.82% |
| % Institutions | 105.36% |
Historical Volatility
HV 10-Day
26.33%
HV 20-Day
31.67%
HV 30-Day
29.63%
HV 60-Day
30.23%
HV Rank
15.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($89.00 target)
1
Strong Buy2
Buy1
HoldLatest News
Ingevity reports second quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.
Business Wire7/29/2026Neutral
NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.
Zacks Investment Research7/17/2026Positive
Ingevity's Evotherm® P35 receives BASt approval in Germany
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.
Business Wire7/16/2026Neutral
Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally?
NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.
Zacks Investment Research7/7/2026Positive
Why Is Ingevity (NGVT) Down 10.8% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research6/5/2026Negative
Ingevity Q1 Earnings Call Highlights
Ingevity NYSE: NGVT reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases.
MarketBeat5/13/2026Positive
NGVT Q1 Earnings Top Estimates on Pricing and FX Tailwinds
Ingevity beats Q1 estimates as pricing actions and FX gains lift sales and earnings, despite weakness in Road Markings and lower asset utilization.
Zacks Investment Research5/12/2026Positive
Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Seeking Alpha5/7/2026Neutral
Ingevity reports first quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity reports first quarter 2026 financial results.
Business Wire5/6/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NGVT and any ticker you trade — then tracks every position and per-strategy win rate.
More BASIC MATERIALS Stocks
Data last updated: 8/18/2026